The Claim
Glutamine, not glucose, is the primary source of oxaloacetate for the TCA cycle in both MUC1-overexpressing and control pancreatic cancer cells under standard and glucose-limited conditions, indicating a fundamental metabolic dependency on glutamine for biosynthesis.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In pancreatic cancer cells, whether or not they overexpress MUC1, oxaloacetate in the TCA cycle is primarily derived from glutamine rather than glucose, regardless of glucose availability, demonstrating that glutamine is essential for biosynthetic processes in these cells.
See the scientific wording
Glutamine, not glucose, is the primary source of oxaloacetate for the TCA cycle in both MUC1-overexpressing and control pancreatic cancer cells under standard and glucose-limited conditions, indicating a fundamental metabolic dependency on glutamine for biosynthesis.
When sugar is scarce, pancreatic cancer cells pull in more glutamine and break it down to make oxaloacetate, which keeps their energy system running and provides the building blocks for DNA. Without enough sugar, they cannot make DNA properly, so they stop dividing.
What the research says
1 studyStudy: Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells
Even when sugar (glucose) is low, these cancer cells still use glutamine (a different nutrient) to make the key molecule needed to keep their energy system running — proving glutamine is their main backup fuel.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.